Navigation Links
New Way To Treat Lupus

Lupus can occur in several forms, but systemic lupus erythematosus (SLE)--usually referred to simply as lupus--is the most serious type. It is an incurable disease marked by inflammation and damage to tissue and organs throughout the body, including the joints, skin, heart, kidney and central nervous system. Lupus is an autoimmune disorder, meaning the immune system mistakenly attacks the body's own tissue.

New research into lupus suggests how the immune system goes awry in the disease//--a discovery scientists say could lead to better, more targeted treatments for lupus in the next few years. The new study suggests how this misguided immune system attack unfolds.

Drugs that suppress the immune system are already part of lupus treatment, but these treatments are nonspecific in their targeting of immune function. And the drugs carry side effects such as nausea, hair loss and an increased risk of infection and cancer. Suppressing only interferon-alpha could potentially provide a more targeted treatment. The findings suggest that a drug that would act against immune system protein called interferon-alpha could fight the disease.


'"/>




Page: 1

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. New FDA Approved Drug To Treat Migraine
4. Treatment for Menieres disease
5. Treatment for pre-menstrual syndrome is ineffective
6. Angiotensin-II-receptor blockers - Treat kidney failure
7. Cipro Has Cheaper Cousins to Treat Anthrax
8. Better Treatment for obesity
9. Gene Treatment for Heart Disease
10. Cyclosporin A Treats Leukemia Complications
11. More People Seeking Treatment for Depression
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Way Treat Lupus

(Date:5/16/2008)...nne,s Bed & Back; Merger Sets Up Healthy Back... Chain, LORTON, Va., May 16 /PRNewswire/ -- Healt...me and workplace back wellness created an,ergonomi...of its rival,JoAnne,s Bed & Back. Healthy Back,s ...nues of $40million. JoAnne,s 16 mid-Atlantic store...
(Date:5/16/2008)...ewswire-USNewswire/ -- This release is,being sent ...ction with the,National Cancer Institute, part of ...t the American Society of Clinical,Oncology meetin...t practice,in about 25 percent of patients with co...o the way colorectal cancers will be staged., * T...
(Date:5/16/2008)...rers gain benefit from calcitriol, an oral form ,...ing activated vitamin D may cut the risk of death ...disease by about one quarter, a new study suggests... patients, those being treated with calcitriol, an...ll risk of death lowered by 26 percent when compar...
(Date:5/16/2008)...o Raise $38 Million for Life-threatening,Disease, ...Walkers in nearly,every state will raise funds for...by participating in GREAT STRIDES, the largest nat...on announced today., May is National Cystic Fibro...eatening genetic disease that causes fatal lung in...
Breaking Medicine News(10 mins):Health News:The Back Wars Come to a Close 2Health News:New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer 2Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2
...as of George Washington University, while presenti..., chopping of vegetables to bite size pieces and c...the reasons that our teeth are growing crooked and...ped teeth may be a direct result of evolution than...
... recent study researchers suggest that women drink...e past // have reported drinking wine is good for ...tential health benefits of alcohol has been done o...te amounts of wine seems to be good for the heart....
...and athletes who live their lives by their sports ...heir oral health for sake of athletic achievements...issue of Journal General Dentistry, most harm caus...nade, sports drinks and energy drinks. At times th...
... is a potentially life-threatening infection for p...on, doctors often prescribe an inhaled drug called...this drug is controversial because some patients e...hi, which causes severe coughing and reduced lung ...
Other Medicine News:
(Date:5/16/2008)...Enables First-Ever PEGylation of a Small Molecule ...tivity, SAN CARLOS, Calif., May 16 /PRNewswire-Fi...nnounced initial results today from a Phase 1,stud...ws significant,anti-tumor activity in patients wit...ates that Nektar,s small molecule PEGylation techn...
(Date:5/16/2008)...y 16 /- Veridex, LLC announced today ...ation of America Holdings,(LabCorp), has commercia...ate cancer. The new assay uses the biological spec...etecting the methylation of the gene,GST-Pi. Methy...ily in,cancer. Veridex is developing the methylati...
(Date:5/16/2008)...tes Statistically Significant Reductions in Select... Abstract to be published in 2008 Proceedings of t...linical Oncology, SAN DIEGO, May 16 /PRNewswire-F... ANX ) announced today that, in a registrational ...d a statistically significant reduction,in general...
(Date:5/15/2008)....J., May 15 /- Eisai Corporation of N...clinical data abstracts about,compounds in the com...eclinical oncology research have been accepted for...erican Society of Clinical Oncology (ASCO),taking... wide variety of abstracts on Eisai marketed produ...
Breaking Medicine Technology:Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 2ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 3ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 4ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 5Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 2Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 3Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 4Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 5Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 6Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 7Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting 8Epigenetic changes discovered in major psychosis 2461 1Epigenetic changes discovered in major psychosis 2461 2Breaking Boundaries Program Honors Colorectal Cancer Survivors for Outstanding Leadership Achievements 14021 1Breaking Boundaries Program Honors Colorectal Cancer Survivors for Outstanding Leadership Achievements 14021 2Breaking Boundaries Program Honors Colorectal Cancer Survivors for Outstanding Leadership Achievements 14021 3Breaking Boundaries Program Honors Colorectal Cancer Survivors for Outstanding Leadership Achievements 14021 4Highmark Blue Shield and National Association Name Area Hospitals as Blue Distinction Centers for Complex and Rare Cancers 14019 1Highmark Blue Shield and National Association Name Area Hospitals as Blue Distinction Centers for Complex and Rare Cancers 14019 2Highmark Blue Shield and National Association Name Area Hospitals as Blue Distinction Centers for Complex and Rare Cancers 14019 3Atlanta Falcons Linebacker Keith Brooking Prepares to Run for Something Better at ING Georgia Marathon 14017 1Atlanta Falcons Linebacker Keith Brooking Prepares to Run for Something Better at ING Georgia Marathon 14017 2Atlanta Falcons Linebacker Keith Brooking Prepares to Run for Something Better at ING Georgia Marathon 14017 3Atlanta Falcons Linebacker Keith Brooking Prepares to Run for Something Better at ING Georgia Marathon 14017 4Atlanta Falcons Linebacker Keith Brooking Prepares to Run for Something Better at ING Georgia Marathon 14017 5
...BUSINESS WIRE)--Apr 17, 2007 -,Seattle Genetics, I...en presentations by the company and its collaborat...ociation for Cancer Research,(AACR) demonstrating ...-drug conjugate (ADC) technology and cancer produc... to cell-killing drugs.,Seattle Genetics, ADC tech...
...ewswire/ -- Micell,Technologies announced today th...ts supercritical fluid (SCF) surface modification,... Society for,Biomaterials 2007 Annual Meeting, Apr...s describe use of Micell and PNNL,s, 2006 R&D,...-eluting stents,containing crystalline drugs, such...
Other Medicine Technology:Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 2Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 3Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 4Micell Technologies Presents Data on Novel Drug-Eluting Stents 2Micell Technologies Presents Data on Novel Drug-Eluting Stents 3
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: